| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Li Yang | Exec. Vice President, Research | C/O SURROZEN, INC., 171 OYSTER POINT BLVD., SUITE 400, SOUTH SAN FRANCISCO | /s/Charles Williams, Attorney-in-Fact for Yang Li | 16 Jun 2025 | 0001990537 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SRZN | Common Stock | Award | $3,224 | +400 | +3.2% | $8.06 | 13,043 | 13 Jun 2025 | Direct | F1 |
| holding | SRZN | Common Stock | 702 | 13 Jun 2025 | See footnote | F2 |
| Id | Content |
|---|---|
| F1 | This reporting person is voluntarily reporting these shares acquired under the Surrozen, Inc. 2021 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). |
| F2 | Held through immediate family members of the Reporting Person. The Reporting Person disclaims beneficial ownership of these shares. |